Depression Relief - Search News

FDA approves Johnson & Johnson’s nasal spray for depression

CNN on MSN · 11h

FDA approves standalone use of J&J’s ketamine-derived depression treatment

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.

Hosted on MSN · 16h

FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.

Fox Business · 14h

J&J's ketamine-derived nasal spray approved by FDA to treat depression

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

Psychology Today3d

New Strategies for Treatment-Resistant Depression

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

Association for Psychological Science6d

Treatment Could Provide Relief for Comorbid Depression and Anxiety

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

WTEN on MSN13h

Magnetic stimulation for brain offering help for major depression

A non-invasive form of treatment for clinical depression is hoping to provide even faster results thanks to new research.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results